Long-term subcutaneous treprostinil (Remodulin) therapy for severe pulmonary arterial hypertension

被引：0
|
作者：
Skoro-Sajer, N.
Bonderman, D.
Harja, E.
Jakowitsch, J.
Maurer, G.
Kneussl, M.
Lang, I. M.
机构：
[1] Vienna Gen Hosp, Dept Cardiol, Vienna, Austria
[2] Wilhelminenspital Stadt Wien, Vienna, Austria
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P595
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] Children with pulmonary arterial hypertension and prostanoid therapy: Long-term hemodynamics
    Siehr, Stephanie L.
    Ivy, D. Dunbar
    Miller-Reed, Kathleen
    Ogawa, Michelle
    Rosenthal, David N.
    Feinstein, Jeffrey A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (05): : 546 - 552
  • [42] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [43] Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension
    Vachiéry, JL
    Hill, N
    Zwicke, D
    Barst, R
    Blackburn, S
    Naeije, R
    CHEST, 2002, 121 (05) : 1561 - 1565
  • [44] Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension
    Onen, Zeynep Pinar
    Yildiz, Onur Akkoca
    Gulbay, Banu Eris
    Karabiyikoglu, Gulseren
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2006, 54 (02): : 177 - 181
  • [45] Treprostinil as a Bridge Therapy to Heart-Lung Transplants in Severe Pulmonary Arterial Hypertension
    Ju, C.
    Lian, Q.
    Wei, B.
    Xu, X.
    He, J.
    Chen, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [46] Long-term outcomes in pulmonary arterial hypertension
    Thenappan, T.
    Palevsky, H. I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 : 42 - 44
  • [47] Three years experience with subcutaneous treprostinil therapy in severe pulmonary hypertension: clinic and haemodynamic assessment
    Jimenez, C.
    Escribano, P.
    Hernandez, F.
    Tello, R.
    Sadia, D.
    Delgado, J. F.
    Gomez-Sanchez, M. A.
    de la Calzada, C. S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 80 - 80
  • [48] Subcutaneous Treprostinil As A Bridge To Transplant In A Case Of Severe Pulmonary Arterial Hypertension Due To Partial Anomalous Pulmonary Venous Return
    Thompson, P.
    Gorbett, D.
    McDaniel, E.
    Daniels, C. J.
    Smith, J. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [49] Long-term exercise capacity and survival in fulmonary arterial hypertension after treprostinil
    Oudiz, RJ
    Okwunosa, I
    CHEST, 2004, 126 (04) : 759S - 759S
  • [50] Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension
    Maestas, Travis
    Hansen, Lillian M.
    Vanderpool, Rebecca R.
    Desai, Ankit A.
    Airhart, Sophia
    Knapp, Shannon M.
    Cohen, Adam
    Feldman, Jeremy
    Rischard, Franz P.
    PULMONARY CIRCULATION, 2018, 8 (04)
12345